Deep Hypothermia Induced Circulatory Arrest

Subscribe to Selected New Research on Deep Hypothermia Induced Circulatory Arrest

242 relevant articles (13 outcomes, 19 trials/studies) found for this Therapy

Description: A technique to arrest the flow of blood by lowering BODY TEMPERATURE to about 20 degrees Centigrade, usually achieved by infusing chilled perfusate. The technique provides a bloodless surgical field for complex surgeries.

Also Known As:

Circulatory Arrest, Deep Hypothermia Induced; Deep Hypothermic Circulatory Arrest

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 4

Thoracic Surgical Procedures: 43

Cardiac Surgical Procedures: 202

Induced Heart Arrest: 1537

Deep Hypothermia Induced Circulatory Arrest: 242

Cardiovascular Surgical Procedures: 18

Cardiac Surgical Procedures: 202

Induced Heart Arrest: 1537

Deep Hypothermia Induced Circulatory Arrest: 242

Experts

1.	Augoustides, John G T: 5 articles (10/2007 - 07/2005)
2.	Monyero, Linda: 2 articles (06/2008 - 05/2007)
3.	Connolly, E Sander: 2 articles (06/2008 - 05/2007)
4.	Komotar, Ricardo J: 2 articles (06/2008 - 05/2007)
5.	Smith, Craig R: 2 articles (06/2008 - 05/2007)
6.	Ducruet, Andrew F: 2 articles (06/2008 - 05/2007)
7.	Shrebnick, Debra B: 2 articles (06/2008 - 05/2007)
8.	Mack, William J: 2 articles (06/2008 - 05/2007)
9.	Angevine, Peter D: 2 articles (06/2008 - 05/2007)
10.	Solomon, Robert A: 2 articles (06/2008 - 05/2007)

Related Diseases

1.	Neoplasms (Cancer) 08/01/1991 - "Cardiopulmonary bypass with deep hypothermic circulatory arrest allows safe and effective removal of renal tumors with extensive thrombi involving the vena cava under controlled circumstances without permanent side effects" 07/01/2008 - "BACKGROUND: The use of deep hypothermic circulatory arrest (CA) during resection of renal tumors with caval extension is limited in many institutes because of possible adverse effects on immune or platelet function" 07/01/2008 - "Deep hypothermic circulatory arrest for resection of renal tumor in the inferior vena cava: beneficial or deleterious?" 04/01/2007 - "Cardiopulmonary bypass and deep hypothermic circulatory arrest are used to resect intracardiac extension of the tumor" 03/01/2007 - "Deep hypothermic circulatory arrest with cardiopulmonary bypass is indicated for complex surgical operations in adult patients involving the aortic arch, thoracoabdominal aorta, cerebral vasculature, and tumors extending into the vena cava and heart" Order ALL the reference details at left...
2.	Intracranial Aneurysm (Cerebral Aneurysm) 01/01/2007 - "The use of deep hypothermic circulatory arrest (DHCA), using groin cannulation with the chest closed (CCDHCA), has improved the surgical treatment of large and giant cerebral aneurysms" 10/01/1999 - "Advances in anesthetic and surgical management, such as induced deep hypothermic circulatory arrest and application of temporary clips, have improved outcome for patients with basilar artery aneurysms" 06/01/2008 - "Deep hypothermic circulatory arrest for complex cerebral aneurysms: lessons learned." 05/01/2007 - "Deep hypothermic circulatory arrest for complex cerebral aneurysms: lessons learned." 03/01/2007 - "Deep hypothermic circulatory arrest (DHCA) continues to be used for that goal during complex aortic arch and large intracranial aneurysm surgeries" Order ALL the reference details at left...
3.	Brain Injuries (Brain Injury) 06/01/2007 - "Lipopolysaccharide preconditioning induces robust protection against brain injury resulting from deep hypothermic circulatory arrest." 12/01/2005 - "There was no significant association between the duration of deep hypothermic circulatory arrest and the degree of severity of overall brain injury, and the pattern of brain injury was similar irrespective of the modality of cardiac surgery" 05/01/2003 - "BACKGROUND: Deep hypothermic circulatory arrest (DHCA), as used in infant heart surgery, carries a risk of brain injury" 01/01/2003 - "OBJECTIVE: Brain injury and altered psychomotor development in infants, children and adults after cardiac surgery using cardiopulmonary bypass (CPB) and deep hypothermic circulatory arrest (DHCA) is still a matter of concern" 10/01/1999 - "BACKGROUND: Organ injury (brain, kidney, and heart) has been reported in up to 30% of pediatric open heart surgery patients after conventional hypothermic non-pulsatile cardiopulmonary bypass (CPB) support with or without deep hypothermic circulatory arrest (DHCA)" Order ALL the reference details at left...
4.	Heart Diseases (Heart Disease) 01/01/2004 - "METHODS: In a study of infants undergoing repair of congenital heart disease, 95% of whom had a period of deep hypothermic circulatory arrest, postoperative temperature data were collected following cardiac surgery" 02/01/2000 - "METHODS: We completed a single-center, prospective, randomized, double-blind, placebo- controlled neuroprotection trial in selected neonates with congenital heart disease requiring operations for which deep hypothermic circulatory arrest was used" 10/01/1999 - "STUDY OBJECTIVE: This study was designed to evaluate the use of retrograde cerebral perfusion (RCP) combined with deep hypothermic circulatory arrest (DHCA) in the treatment of complex congenital and adult cardiac disease" 10/01/2006 - "OBJECTIVE: Concern over neurologic injury limits safe duration of deep hypothermic circulatory arrest (DHCA) in surgery for congenital cardiac disease" 04/01/2006 - "OBJECTIVE: Neurodevelopmental impairments after repair of congenital heart disease with cardiopulmonary bypass and deep hypothermic circulatory arrest continue to affect the lives of children" Order ALL the reference details at left...
5.	Edema 01/01/2002 - "Among the advantages of deep hypothermic circulatory arrest are decreased exposure to cardiopulmonary bypass with its sequelae, improved operative field exposure, avoidance of multiple cannulas, and reduced postoperative edema" 11/10/1998 - "This study assessed the effect of continuous high-volume HF during CPB on systemic edema formation and pulmonary function after deep hypothermic circulatory arrest (DHCA)" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Oxygen
2.	Aprotinin (Trasylol)
3.	Phenoxybenzamine
4.	coenzyme Q10 (CoQ10)
5.	Heparin (Liquaemin)
6.	recombinant FVIIa (rFVIIa)
7.	Factor VIIa (Activated Factor VII)
8.	Poly Adenosine Diphosphate Ribose
9.	Erythropoietin
10.	Deferoxamine (Desferal)

Related Therapies and Procedures

1.	Cardiopulmonary Bypass (Heart-Lung Bypass)
2.	Rewarming
3.	Extracorporeal Circulation
4.	Thrombectomy
5.	Ligation

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 18472 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>